West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 435,800 | 521,400 | 791,300 | 628,500 | 509,700 |
| Receivables | 712,000 | 685,600 | 574,400 | 625,000 | 582,400 |
| Inventories | 447,400 | 452,600 | 443,900 | 438,000 | 421,100 |
| Other current assets | 212,300 | 167,200 | 168,600 | 131,800 | 167,700 |
| TOTAL | $1,807,500 | $1,826,800 | $1,978,200 | $1,823,300 | $1,680,900 |
| Non-Current Assets | |||||
| PPE Net | 1,686,300 | 1,702,200 | 1,726,400 | 1,740,600 | 1,722,000 |
| Investments And Advances | 207,700 | 209,200 | 212,300 | 220,900 | 224,700 |
| Intangibles | 115,100 | 116,200 | 117,600 | 119,500 | 120,600 |
| Other Non-Current Assets | 259,800 | 255,400 | 235,500 | 201,500 | 204,600 |
| TOTAL | $2,268,900 | $2,283,000 | $2,291,800 | $2,282,500 | $2,271,900 |
| Total Assets | $4,076,400 | $4,109,800 | $4,270,000 | $4,105,800 | $3,952,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 252,700 | 252,300 | 253,700 | 255,800 | 239,000 |
| Accrued Expenses | 131,100 | 119,200 | 175,100 | 111,800 | 93,400 |
| Other current liabilities | 171,100 | 202,200 | 175,300 | 213,100 | 222,800 |
| TOTAL | $640,500 | $674,000 | $654,900 | $635,400 | $604,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 202,900 | 202,800 | 202,800 | 202,700 | 202,600 |
| Other Non-Current Liabilities | 206,500 | 208,100 | 199,800 | 179,900 | 181,000 |
| TOTAL | $445,700 | $445,400 | $439,100 | $418,900 | $419,100 |
| Total Liabilities | $1,086,200 | $1,119,400 | $1,094,000 | $1,054,300 | $1,023,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,376 | 70,648 | 72,021 | 71,943 | 71,907 |
| Common Shares | 18,800 | 18,800 | 18,800 | 18,800 | 18,800 |
| Retained earnings | 4,624,100 | 4,475,900 | 4,374,900 | 4,262,400 | 4,139,200 |
| Other shareholders' equity | -140,700 | -125,300 | -105,700 | -102,700 | -88,900 |
| TOTAL | $2,990,200 | $2,990,400 | $3,176,000 | $3,051,500 | $2,929,100 |
| Total Liabilities And Equity | $4,076,400 | $4,109,800 | $4,270,000 | $4,105,800 | $3,952,800 |